Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.
Schally
Andrew V
AV
Department of Pathology and Department of Medicine, Division of Hematology/Oncology, VA Medical Center, Miami, FL, USA. andrew.schally@va.gov
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone